Cytokines and serotonin transporter in patients with major depression
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235 · cited 1×
“Several studies had demonstrated that major depression occurred because of abnormal changes in neurotransmitter function, and alterations in the endocrine and immune functions (Syvalahti, 1994; Connor and Leonard, 1998; Anisman and Merali, 2002; Capuron and Dantzer, 2003; Schiepers et al., 2005).”
BackgroundGlucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147
Major Depression and Activation of The Inflammatory Response System
Maes, M. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_2 · Cited by 617
Capuron, L., Ravaud, A., Neveu, P. J., Miller, A. H., Maes, M., & Dantzer, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000995 · Cited by 473
Tuglu, C., Kara, S. H., Caliyurt, O., Vardar, E., & Abay, E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1566-z · Cited by 391
Effects of antidepressants on the production of cytokines
Kenis, G., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003164 · Cited by 370 · cited 1×
“However, studies on these immune parameters appeared to be controversial (Seidel et al., 1995; Sluzewska et al., 1995; Weizman et al., 1994; Kenis and Maes, 2002; Steptoe et al., 2003; Brambilla et al., 2004; Kubera et al., 2004).”
BackgroundFrommberger, U. H., Bauer, J., Haselbauer, P., Fräulin, A., Riemann, D., & Berger, M. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02900219 · Cited by 362
Cytokine Production and Serum Proteins in Depression
SEIDEL, A., AROLT, V., HUNSTIGER, M., RINK, L., BEHNISCH, A., & KIRCHNER, H. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03604.x · Cited by 244 · cited 1×
“However, studies on these immune parameters appeared to be controversial (Seidel et al., 1995; Sluzewska et al., 1995; Weizman et al., 1994; Kenis and Maes, 2002; Steptoe et al., 2003; Brambilla et al., 2004; Kubera et al., 2004).”
BackgroundHestad, K. A., Tønseth, S., Støen, C. D., Ueland, T., & Aukrust, P. (2003) · The Journal of ECT · doi:10.1097/00124509-200312000-00002 · Cited by 235 · cited 3×
“…IL-6, IFNγ, and TNFα) from peripheral blood mononuclear cells (PBMC) in depressed patients (Sluzewska et al., 1995, 1996; Song et al., 1998; Anisman and Merali, 2002; Hestad et al., 2003; Suarez et al., 2003; Tuglu et al., 2003; O'Brien et al., 2004; Thomas et al., 2005) had also been reported.”
Background
Cited by
Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression
Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J. F., & Dinan, T. G. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.005 · Cited by 999
The vascular depression hypothesis: mechanisms linking vascular disease with depression
Taylor, W. D., Aizenstein, H. J., & Alexopoulos, G. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.20 · Cited by 923
The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
Müller, N., & Schwarz, M. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002006 · Cited by 670
O’Connor, M.-F., Bower, J. E., Cho, H. J., Creswell, J. D., Dimitrov, S., Hamby, M. E., Hoyt, M. A., Martin, J. L., Robles, T. F., Sloan, E. K., et al. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.04.005 · Cited by 500
Dahl, J., Ormstad, H., Aass, H. C. D., Malt, U. F., Bendz, L. T., Sandvik, L., Brundin, L., & Andreassen, O. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.019 · Cited by 424
The neuropoietic cytokine family in development, plasticity, disease and injury
Bauer, S., Kerr, B. J., & Patterson, P. H. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2054 · Cited by 419
Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims
Pandey, G. N., Rizavi, H. S., Ren, X., Fareed, J., Hoppensteadt, D. A., Roberts, R. C., Conley, R. R., & Dwivedi, Y. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.08.006 · Cited by 378
“, 2000) and also can affect the 5HT transporter (Tsao et al., 2006).”
BackgroundNeurobiology of depression, fibromyalgia and neuropathic pain
Maletic, V. (2009) · Frontiers in Bioscience · doi:10.2741/3598 · Cited by 366
Khairova, R. A., Machado-Vieira, R., Du, J., & Manji, H. K. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709009924 · Cited by 350
Vocal Acoustic Biomarkers of Depression Severity and Treatment Response
Mundt, J. C., Vogel, A. P., Feltner, D. E., & Lenderking, W. R. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.015 · Cited by 323
A mouse model of depression induced by repeated corticosterone injections
Zhao, Y., Ma, R., Shen, J., Su, H., Xing, D., & Du, L. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.005 · Cited by 323
A Dialogue between the Immune System and Brain, Spoken in the Language of Serotonin
Baganz, N. L., & Blakely, R. D. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn300186b · Cited by 309
Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder
Eller, T., Vasar, V., Shlik, J., & Maron, E. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.015 · Cited by 290
A detailed examination of cytokine abnormalities in Major Depressive Disorder
Simon, N. M., McNamara, K., Chow, C. W., Maser, R. S., Papakostas, G. I., Pollack, M. H., Nierenberg, A. A., Fava, M., & Wong, K. K. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.06.004 · Cited by 286
“…MCP-1, IL-1α, IL-1β, IL-2, IL-6, IL-8 and IFNγ (e.g., see Schiepers et al, 2005 for recent review) (Marques-Deak et al., 2007, O'Brien S et al., 2007, Tsao et al., 2006, Anisman et al., 1999, Maes et al., 1999, Rajagopalan et al., 2001, Pace et al., 2006, Kaestner et al., 2005, Suarez et al.,…”
BackgroundWhat's wrong with my mouse model?
Kalueff, A. V., Wheaton, M., & Murphy, D. L. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.01.023 · Cited by 285
“Among recent developments in stress neurobiology, the conept of cytokine-mediated “sickness behavior” [9,23,83,84] is articularly attractive in regard to experimental modeling of nxiety and depression, both known to be associated with ytokine disregulation [60,84,91,216,290,343].”
BackgroundShelton, R. C., & Miller, A. H. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.004 · Cited by 261
Loftis, J. M., Huckans, M., & Morasco, B. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.015 · Cited by 252
A psychoneuroimmunological review on cytokines involved in antidepressant treatment response
Janssen, D. G. A., Caniato, R. N., Verster, J. C., & Baune, B. T. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1103 · Cited by 240
“Antidepressants reduce serotonin transporter levels, which have been shown to be correlated to pro-inflammatory cytokine levels (Tsao et al., 2006).”
BackgroundGene expression in major depressive disorder
Jansen, R., Penninx, B. W. J. H., Madar, V, Xia, K., Milaneschi, Y., Hottenga, J. J., Hammerschlag, A. R., Beekman, A., van der Wee, N., Smit, J. H., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.57 · Cited by 224
Peripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197
Immune system dysregulation in adolescent major depressive disorder
Gabbay, V., Klein, R. G., Alonso, C. M., Babb, J. S., Nishawala, M., De Jesus, G., Hirsch, G. S., Hottinger-Blanc, P. M. Z., & Gonzalez, C. J. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.07.022 · Cited by 153
“Additional evidence linking IFN-γ to MDD is derived from reports that antidepressants have a common, negative immuno-regulatory effect, suppressing IFN-γ, IFN-γ/IL-10 production ratio, and IFN-γ gene expression (Kubera et al., 2001; Maes et al., 1999; Tsao et al., 2006).”
BackgroundInflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis
Cattaneo, A., Macchi, F., Plazzotta, G., Veronica, B., Bocchio-Chiavetto, L., Riva, M. A., & Pariante, C. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00040 · Cited by 152
“…colleagues found higher mRNA levels of TNF-α, IL-1β, IL-6 and INF-α in the Peripheral Blood Mononuclear Cells (PBMCs) of patients suffering from MDD (Tsao et al., 2006), and our group has also shown an increased expression of cytokine mRNA levels in the leukocytes of drug free depressed patients…”
BackgroundSavitz, J., Frank, M. B., Victor, T., Bebak, M., Marino, J. H., Bellgowan, P. S. F., McKinney, B. A., Bodurka, J., Kent Teague, T., & Drevets, W. C. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.007 · Cited by 146
The importance of n-6/n-3 fatty acids ratio in the major depressive disorder
Husted, K. S., & Bouzinova, E. V. (2016) · Medicina · doi:10.1016/j.medici.2016.05.003 · Cited by 142
“have demonstrated an increased level of SERT mRNA in leukocytes of depressed patients [84].”
BackgroundHernández, M. E., Mendieta, D., Martínez-Fong, D., Loría, F., Moreno, J., Estrada, I., Bojalil, R., & Pavón, L. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.08.001 · Cited by 140
A Preliminary Study of Cytokines in Suicidal and Nonsuicidal Adolescents with Major Depression
Gabbay, V., Klein, R. G., Guttman, L. E., Babb, J. S., Alonso, C. M., Nishawala, M., Katz, Y., Gaite, M. R., & Gonzalez, C. J. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0140 · Cited by 136
“…IFN-g to be elevated in nonsuicidal MDD patients as well, consistent with many adult MDD studies (Maes et al. 1994; Seidel et al. 1995; Myint et al. 2005; Tsao et al. 2006; Simon et al. 2008), it seems that elevated plasma IFN-g may be related to major depression rather than to active suicidality.”
Liu, S., Guo, R., Liu, F., Yuan, Q., Yu, Y., & Ren, F. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s243551 · Cited by 130
“46,47 Gut microbiota are essential for immune development in the host, which directly affects the role of peripheral immune cells in the central nervous system.48 High levels of pro-inflammatory cytokines contribute toward inhibition of the negative feedback function of the HPA axis, improving blood-brain barrier perm…”
BackgroundDepression pathogenesis and treatment: what can we learn from blood mRNA expression?
Hepgul, N., Cattaneo, A., Zunszain, P. A., & Pariante, C. M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-28 · Cited by 127
Regulatory T cells increased while IL-1β decreased during antidepressant therapy
Himmerich, H., Milenović, S., Fulda, S., Plümäkers, B., Sheldrick, A. J., Michel, T. M., Kircher, T., & Rink, L. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.03.005 · Cited by 116
Jazayeri, S., Keshavarz, S. A., Tehrani-Doost, M., Djalali, M., Hosseini, M., Amini, H., Chamari, M., & Djazayery, A. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.04.013 · Cited by 116
“This was not consistent with most previous findings about anti-depressants effects on inflammatory cytokines (Leo et al., 2006; Tsao et al., 2006; Kim et al., 2007).”
Serotonin and molecular neuroimaging in humans using PET
Saulin, A., Savli, M., & Lanzenberger, R. (2012) · Amino Acids · doi:10.1007/s00726-011-1078-9 · Cited by 113
Martino, M., Rocchi, G., Escelsior, A., & Fornaro, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604542 · Cited by 111
“In rigorous and long term clinical study, SSRIs seem to increase Th1 cytokines, such as IL-1β, IL-2 and IFN-γ, and decrease Th2 cytokines, such as IL-4, IL-10 and IL-13, and cortisol levels after 52 weeks treatment in depressed patients [252], although other in vitro and short term ex-vivo studies reported conflicting…”
ResultBlood biomarkers and treatment response in major depression
Mora, C., Zonca, V., Riva, M. A., & Cattaneo, A. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1470927 · Cited by 107
“, 2006 [101] IL11 12 weeks of treatment Escitalopram (SSRI) Powell et al.”
BackgroundFredericks, C. A., Drabant, E. M., Edge, M. D., Tillie, J. M., Hallmayer, J., Ramel, W., Kuo, J. R., Mackey, S., Gross, J. J., & Dhabhar, F. S. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.10.014 · Cited by 74
Interleukin-1 β-Targeted Treatment Strategies in Inflammatory Depression: Toward Personalized Care
Ellul, P., Boyer, L., Groc, L., Leboyer, M., & Fond, G. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12656 · Cited by 65
Powell, T. R., McGuffin, P., D'Souza, U. M., Cohen-Woods, S., Hosang, G. M., Martin, C., Matthews, K., Day, R. K., Farmer, A. E., Tansey, K. E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091076 · Cited by 45
Metadata
- Authors
- Tsao, C.-W., Lin, Y.-S., Chen, C.-C., Bai, C.-H., & Wu, S.-R.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2006-07
- Volume
- 30
- Issue
- 5
- Pages
- 899-905
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2039399819
- Cited by
- 211
- References
- 20
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.